EQWL - ETF AI Analysis
Top Page
Invesco S&P 100 Equal Weight ETF (EQWL)
Rating:72Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which helps reduce the impact if any single industry runs into trouble.
Equal-Weight Approach
Because the ETF gives similar weight to each stock in the S&P 100, it avoids relying too heavily on a few mega-cap names and allows more companies to contribute to returns.
Solid Recent Performance
The ETF has shown steady gains over the past few months and year-to-date, indicating that its mix of holdings has been working well in the current market.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, so it offers little geographic diversification if the U.S. market weakens.
Mixed Performance Among Top Holdings
While several top positions have delivered strong gains, a few key holdings have been weak, which can drag on overall results.
Moderate Expense Ratio
The fund’s fees are not especially high but are also not the lowest among large-cap index ETFs, slightly reducing the net return to investors over time.
EQWL vs. SPDR S&P 500 ETF (SPY)
AUM2.90B
RegionNorth America
Expense Ratio0.25%
Beta0.81
IssuerInvesco
Inception DateDec 01, 2006
Dividend Yield1.52%
Asset ClassEquity
Index TrackedS&P 100 Equal Weighted
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume89,617
30 Day Avg. Volume85,427
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
156.10Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering102
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EQWL Summary
The Invesco S&P 100 Equal Weight ETF (EQWL) tracks the S&P 100 Equal Weighted Index, which includes 100 of the largest U.S. companies but gives each one a similar-sized place in the fund instead of letting the biggest companies dominate. It holds well-known names like JPMorgan Chase and Bank of America, along with major tech, health care, and industrial firms. Someone might invest in EQWL for broad, diversified exposure to leading U.S. companies while avoiding heavy concentration in a few mega-cap stocks. A key risk is that it can still rise and fall with the overall U.S. stock market.
How much will it cost me?The Invesco S&P 100 Equal Weight ETF (EQWL) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it uses an equal weight strategy, which requires more active management compared to passively managed funds that track market-cap weighted indexes.
What would affect this ETF?The Invesco S&P 100 Equal Weight ETF (EQWL) could benefit from strong performance in the U.S. economy, particularly in sectors like technology, financials, and health care, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which could pressure growth-oriented sectors like technology, and economic slowdowns that could impact consumer spending and industrial activity. Its equal-weight strategy helps reduce reliance on any single stock, but broad market downturns or sector-specific issues could still negatively affect the ETF.
EQWL Top 10 Holdings
EQWL is powered by a mix of rising health care and tech names, with Merck and Amgen acting like steady engines thanks to strong drug pipelines and solid earnings. Thermo Fisher and Microsoft add more fuel, benefiting from demand in life sciences and cloud/AI, respectively. On the flip side, Abbott has been lagging, and Capital One is dragging the fund as investors worry about consumer credit. With equal weight across these U.S. large caps and a tilt toward health care and technology, no single giant dominates the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Salesforce | 1.43% | $41.09M | $213.35B | 3.38% | 80 Outperform | |
| Palantir Technologies | 1.26% | $36.27M | $418.93B | 13.86% | 74 Outperform | |
| ServiceNow | 1.25% | $36.08M | $146.06B | -22.71% | 75 Outperform | |
| Amgen | 1.22% | $35.06M | $236.38B | 54.15% | 77 Outperform | |
| Thermo Fisher | 1.20% | $34.48M | $226.94B | 24.60% | 72 Outperform | |
| Merck & Company | 1.19% | $34.19M | $370.89B | 77.46% | 80 Outperform | |
| Microsoft | 1.18% | $34.07M | $3.71T | 0.95% | 79 Outperform | |
| Gilead Sciences | 1.17% | $33.67M | $187.23B | 31.24% | 78 Outperform | |
| Deere | 1.17% | $33.57M | $186.99B | 46.54% | 66 Neutral | |
| Capital One Financial | 1.16% | $33.49M | $134.72B | -0.87% | 71 Outperform |
EQWL Technical Analysis
Positive
―
Price Trends
132.03
Positive
128.40
Positive
123.09
Positive
Market Momentum
0.73
Positive
54.11
Neutral
56.43
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EQWL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 134.71, equal to the 50-day MA of 132.03, and equal to the 200-day MA of 123.09, indicating a neutral trend. The MACD of 0.73 indicates Positive momentum. The RSI at 54.11 is Neutral, neither overbought nor oversold. The STOCH value of 56.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EQWL.
EQWL Peer Comparison
Comparison Results
Performance Comparison
EQWL
Invesco S&P 100 Equal Weight ETF
134.37
23.88
21.61%
JQUA
JPMorgan U.S. Quality Factor ETF
―
―
―
VONE
Vanguard Russell 1000 ETF
―
―
―
TCAF
T. Rowe Price Capital Appreciation Equity ETF
―
―
―
FELC
Fidelity Enhanced Large Cap Core ETF
―
―
―
QYLD
Global X NASDAQ 100 Covered Call ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents